Financials

  • Market Capitalization 44.56 B
  • Employee 883
  • Founded 2014
  • CEO N/A
  • Website www.revmed.com
  • Headquarter Delaware, United States
  • FIGI BBG00829F4P8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-13.39
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
263
ARGX
argenx SE - American Depositary Shares
1023.21 USD-3.37%-0.01%+18.84%+43.71%63.32 B USD
296
MRNA
Moderna, Inc. - Common Stock
137.99 USD-3.35%-3.30%+146.94%+476.64%55.09 B USD
445
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
237.10 USD+0.23%+0.52%+5.36%-46.82%31.73 B USD
488
RPRX
Royalty Pharma plc - Class A Ordinary Shares
60.85 USD-1.73%-0.44%+4.11%+63.31%27.17 B USD

Notizie